GB1296431A - - Google Patents
Info
- Publication number
- GB1296431A GB1296431A GB1296431DA GB1296431A GB 1296431 A GB1296431 A GB 1296431A GB 1296431D A GB1296431D A GB 1296431DA GB 1296431 A GB1296431 A GB 1296431A
- Authority
- GB
- United Kingdom
- Prior art keywords
- alkoxy
- formula
- treatment
- addition salts
- acid addition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
Abstract
1296431 2 - Phenoxyalkylaminomethyl chromanes WARD BLENKINSOP & CO Ltd 19 April 1971 [26 Jan 1970] 3748/70 Heading C2C Novel compounds of the Formula. (I) where R and R<SP>1</SP> are H, halo, or C 1-2 alkyl or alkoxy, n is an integer from 2 to 6 and R<SP>2</SP> and R<SP>3</SP> are H, or C 1-2 alkoxy, and acid addition salts thereof are obtained by reacting a 2-substituted methyl chromane (II) in which one of X and Z is a halogen atom and the other a primary amino group, the resulting hydrohalide being optionally decomposed by treatment with an acid acceptor, and a salt being formed by treatment with a corresponding acid. Pharmaceutical compositions having hypotensive and adrenolytic and adrenergic blocking properties comprise compounds of Formula (I) and their pharmacologically acceptable acid addition salts together with an inert carrier, preferably for administration in the form of tablets, capsules or suppositories or by the intravenous route.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB374870 | 1970-01-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1296431A true GB1296431A (en) | 1972-11-15 |
Family
ID=9764239
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1296431D Expired GB1296431A (en) | 1970-01-26 | 1970-01-26 |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB1296431A (en) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4321270A (en) | 1981-01-29 | 1982-03-23 | E. R. Squibb & Sons, Inc. | Substituted chromans |
US4360532A (en) * | 1981-01-29 | 1982-11-23 | E. R. Squibb & Sons, Inc. | Substituted chromans |
US5747528A (en) * | 1996-02-21 | 1998-05-05 | Warner-Lambert Company | Chroman derivatives as anti-oxidants |
WO2003040382A1 (en) * | 2001-11-09 | 2003-05-15 | Kaneka Corporation | Process for producing optically active chroman derivative and intermediate |
-
1970
- 1970-01-26 GB GB1296431D patent/GB1296431A/en not_active Expired
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4321270A (en) | 1981-01-29 | 1982-03-23 | E. R. Squibb & Sons, Inc. | Substituted chromans |
FR2498601A1 (en) * | 1981-01-29 | 1982-07-30 | Squibb & Sons Inc | NOVEL SUBSTITUTED CHROMANS USEFUL AS ANTI-INFLAMMATORY |
US4360532A (en) * | 1981-01-29 | 1982-11-23 | E. R. Squibb & Sons, Inc. | Substituted chromans |
US5747528A (en) * | 1996-02-21 | 1998-05-05 | Warner-Lambert Company | Chroman derivatives as anti-oxidants |
WO2003040382A1 (en) * | 2001-11-09 | 2003-05-15 | Kaneka Corporation | Process for producing optically active chroman derivative and intermediate |
EP1445324A1 (en) * | 2001-11-09 | 2004-08-11 | Kaneka Corporation | Process for producing optically active chroman derivative and intermediate |
EP1445324A4 (en) * | 2001-11-09 | 2005-02-16 | Kaneka Corp | Process for producing optically active chroman derivative and intermediate |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1260848A (en) | Propanolamine derivatives | |
GB1285016A (en) | 3,4-dihydroisoquinoline derivatives | |
GB1409768A (en) | Hererocyclic derivatives of a guanidine | |
GB1293072A (en) | Dibenzo-oxazocine and dibenzo-thiazocine derivatives | |
GB1228736A (en) | ||
GB1296431A (en) | ||
GB1323659A (en) | Piperazine derivatives methods for their production and pharmaceuticl compositions containing them | |
GB1069797A (en) | ª-aminoketone derivatives | |
GB1244975A (en) | Benzodioxane derivatives | |
GB1268587A (en) | Phloramine derivatives | |
GB1053843A (en) | ||
GB1156781A (en) | New Heterocyclic Compounds | |
GB1186495A (en) | 0-[3-(4-Fluorobenzoyl) Proplyl]-4-Substituted Piperazines, their Acid Addition Salts and their method of preparation | |
GB1398687A (en) | Substituted oxazolidinones and pharmaceutical uses thereof | |
GB1292787A (en) | Benzodioxane derivatives and pharmaceutical compositions containing them | |
GB1353536A (en) | Antiviral compositions containing bisbasic ethers and thioethers of xanthene and xanthen-9-ones and methods of treating viruses therewith | |
GB1462521A (en) | Triazole derivatives | |
GB1281433A (en) | Allene polymines and manufacture thereof | |
GB1342760A (en) | Substituted phthalazines | |
GB1345214A (en) | Isoxazoles | |
GB1254270A (en) | Benzoxazepine derivatives | |
GB1299566A (en) | Bis-basic ethers of 2,6- and 2,7-dihydroxyanthraquinones | |
GB1369888A (en) | Substituted amidines | |
GB1335403A (en) | Pharmaceutical compositions containing benzofuran derivatives | |
GB1139146A (en) | Benzofuran derivatives and processes for preparing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed | ||
PLE | Entries relating assignments, transmissions, licences in the register of patents | ||
PCNP | Patent ceased through non-payment of renewal fee |